Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like ß-Coronaviruses.
ACS Chem Biol
; 17(7): 1937-1950, 2022 07 15.
Статья
в английский
| MEDLINE | ID: covidwho-2106315
ABSTRACT
Inhibition of the protein kinase CSNK2 with any of 30 specific and selective inhibitors representing different chemotypes, blocked replication of pathogenic human, bat, and murine ß-coronaviruses. The potency of in-cell CSNK2A target engagement across the set of inhibitors correlated with antiviral activity and genetic knockdown confirmed the essential role of the CSNK2 holoenzyme in ß-coronavirus replication. Spike protein endocytosis was blocked by CSNK2A inhibition, indicating that antiviral activity was due in part to a suppression of viral entry. CSNK2A inhibition may be a viable target for the development of anti-SARS-like ß-coronavirus drugs.
Полный текст:
Имеется в наличии
Коллекция:
Международные базы данных
база данных:
MEDLINE
Основная тема:
Coronavirus Infections
/
Coronavirus
Пределы темы:
Животные
/
Люди
Язык:
английский
Журнал:
ACS Chem Biol
Год:
2022
Тип:
Статья
Аффилированная страна:
Acschembio.2c00378
Документы, близкие по теме
MEDLINE
...
LILACS
LIS